SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, Inc. (Nasdaq:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs by applying proprietary technology, scientific expertise and unique capabilities for targeting the liver and liver pathways, announced today financial results for the first quarter ended March 31, 2007 and commented on first quarter achievements.
